Federal contract award
75N91021F00006
SUPPORT SERVICES, OPERATIONS COORDINATOR 2 FOR THE COORDINATING CENTER FOR CLINICAL TRIALS, NATIONAL CANCER INSTITUTE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NIH NCI |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | R431 — SUPPORT- PROFESSIONAL: HUMAN RESOURCES |
| Parent award / vehicle | HHSN261201700001B |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $400.6K |
| Current contract value | $400.6K |
| Potential contract value / ceiling | $430.3K |
| Start date | May 17, 2021 |
| Current end date | May 16, 2024 |
| Potential end date | May 16, 2024 |
| Latest award activity | Aug 25, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 25, 2026 | P00004 | $-29.7K | TO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS. |
| May 16, 2023 | P00003 | $146.3K | OPERATIONS COORDINATOR 2 FOR THE CCT, NCI. |
| Dec 20, 2022 | P00002 | $0 | TO UPDATE COR TO DR. GISELE SAROSY FROM SARAH FABIAN |
| May 12, 2022 | P00001 | $143.4K | EXERCISE OPTION PERIOD 1: SUPPORT SERVICES, OPERATIONS COORDINATOR 2 FOR THE COORDINATING CENTER FOR CLINICAL TRIALS, NATIONAL CANCER INSTITUTE, POP 5/16/2022-5/17/2023 |
| May 10, 2021 | 0 | $140.6K | SUPPORT SERVICES, OPERATIONS COORDINATOR 2 FOR THE COORDINATING CENTER FOR CLINICAL TRIALS, NATIONAL CANCER INSTITUTE |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.